David Shaw’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-13,700
Closed -$320K 4837
2026
Q1
$320K Sell
13,700
-14,800
-52% -$268K ﹤0.01% 4051
2025
Q4
$404K Sell
28,500
-4,600
-14% -$87K ﹤0.01% 4021
2025
Q3
$820K Buy
+33,100
New +$738K ﹤0.01% 3581
2014
Q1
Sell
-15,600
Closed -$738K 4230
2013
Q4
$738K Sell
15,600
-20,000
-56% -$869K ﹤0.01% 3421
2013
Q3
$1.4M Buy
35,600
+15,600
+78% +$579K ﹤0.01% 2740
2013
Q2
$661K Buy
+20,000
New +$649K ﹤0.01% 3034

Other funds holding ACHC

David Shaw's ACHC Position: Q2 2026 in Review

David Shaw reduced its Acadia Healthcare (ACHC) stake by 42% in Q2 2026, selling an estimated $1.01M and leaving 55,336 shares worth $1.63M. The position accounts for ﹤0.01% of the portfolio, ranked #3369.

David Shaw first reported a position in ACHC in Q2 2014 and has held it in 26 quarters since. The position peaked at $54.4M in Q3 2025. 312 funds tracked by Wall St. Rank hold ACHC as of Q2 2026.

  • David Shaw held 55,336 shares of Acadia Healthcare worth $1.63M as of Q2 2026.
  • David Shaw sold 39,385 Acadia Healthcare shares in Q2 2026, an estimated $1.01M.
  • Acadia Healthcare made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #3369 holding.
  • David Shaw first reported a position in Acadia Healthcare in Q2 2014 and has held it in 26 quarters since.
  • David Shaw's Acadia Healthcare position peaked at $54.4M in Q3 2025.
  • 312 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.